ascentage.com (AAPGV) Cash Funds per Single Share

Corporate emblem and logo of Ascentage (AAPGV)

Ascentage Pharma Group (AAPGV) combines leading biochemists and state-of-the-art laboratories to study apoptosis. The implementation of robotic systems in testing minimizes manual labor, which is reflected in the change in cash per share, where the value settled at 3.00. Scaling the portfolio through global partnerships in the US and China should ensure the company reaches stable net profit.

AAPGV: Ascentage Pharma Cash per Share 01/25/2025 - 11/20/2026

Comprehensive metric breakdowns and analytics for Ascentage (AAPGV)

- market price and analyst price targets:
- cash position and cash flow details:
General company analysis:Ascentage - AAPGV
Mass-produced product of Ascentage Pharma Group Ltd

The financial stability of Ascentage Pharma Group (AAPGV) is based on its ability to fund costly developments in targeted oncology. This indicator is calculated by dividing the total volume of liquid assets by the number of shares outstanding. The metric determines the actual size of the cash cushion available per share. High values confirm the company's ability to sustain breakthrough research into apoptosis inhibitors. Analyzing the history of cash per share allows for an assessment of the balance between capital security and capital efficiency.

Analysis of competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|w2.cytomed.sg - Cash Calculated per Single Share|Curis Corp (CRIS) - Cash Funds per Share|Cash on Hand per Share Apollomics Corp (APLM)|Cash Funds per Share Tharimmune|Cash per Share advanbiomed.com|Cash Funds per Share Genprex, Inc (GNPX)|Cash Funds Calculated per Share Calidi Biotherapeutics, Inc.|Cash per Share SBFM (Sunshine Biopharma Inc.)|XBIO - Cash per Single Share|SLRX: Cash per Single Share|Amount of Cash per Share PPBT (Purple Biotech Ltd.)|AONC: Cash per Share|Cash on Hand per Share BeOne Medicines (BGNE)|Cash Funds per Share Checkpoint Therapeutics, Inc.|Cash per Single Share Elevation Oncology (ELEV)|Cash Funds per Share iCAD Corp (ICAD)|Cash per Single Share Ikena IKNA|Cash per Share NTBL (notablelabs.com)|VIRX - Cash per Single Share|MOR: Cash per Single Share|NAYA - Cash per Share